Eledon Pharmaceuticals, Inc. (ELDN)
3.465
+0.06
(+1.61%)
USD |
NASDAQ |
Aug 25, 16:00
3.465
0.00 (0.00%)
After-Hours: 19:12
Eledon Pharmaceuticals Total Assets (Quarterly) : 126.09M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 126.09M |
| March 31, 2026 | 146.67M |
| December 31, 2025 | 237.60M |
| September 30, 2025 | 129.86M |
| June 30, 2025 | 144.91M |
| March 31, 2025 | 161.31M |
| December 31, 2024 | 229.44M |
| September 30, 2024 | 114.58M |
| June 30, 2024 | 120.48M |
| March 31, 2024 | 80.82M |
| December 31, 2023 | 125.89M |
| September 30, 2023 | 96.07M |
| June 30, 2023 | 106.78M |
| March 31, 2023 | 82.31M |
| December 31, 2022 | 92.79M |
| September 30, 2022 | 149.59M |
| June 30, 2022 | 154.71M |
| March 31, 2022 | 161.38M |
| December 31, 2021 | 170.55M |
| September 30, 2021 | 177.17M |
| June 30, 2021 | 184.30M |
| March 31, 2021 | 191.68M |
| December 31, 2020 | 197.18M |
| September 30, 2020 | 192.58M |
| June 30, 2020 | 10.50M |
| Date | Value |
|---|---|
| March 31, 2020 | 13.72M |
| December 31, 2019 | 10.93M |
| September 30, 2019 | 15.22M |
| June 30, 2019 | 18.22M |
| March 31, 2019 | 13.45M |
| December 31, 2018 | 17.03M |
| September 30, 2018 | 19.93M |
| June 30, 2018 | 22.96M |
| March 31, 2018 | 25.92M |
| December 31, 2017 | 20.89M |
| September 30, 2017 | 23.02M |
| June 30, 2017 | 26.84M |
| March 31, 2017 | 25.83M |
| December 31, 2016 | 1.196M |
| September 30, 2016 | 36.72M |
| June 30, 2016 | 46.86M |
| March 31, 2016 | 57.71M |
| December 31, 2015 | 67.97M |
| September 30, 2015 | 77.61M |
| June 30, 2015 | 87.41M |
| March 31, 2015 | 96.65M |
| December 31, 2014 | 107.74M |
| September 30, 2014 | 106.98M |
| June 30, 2014 | 23.42M |
| March 31, 2014 | 28.00M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 27.42B |
| Viking Therapeutics, Inc. | 521.90M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 54.06M |
| Shareholders Equity (Quarterly) | 72.03M |
| Debt to Equity Ratio | 0.0065 |
| Current Ratio | 7.896 |
| Net Debt Paydown Yield | 0.03% |